慢性肾脏病中的心力衰竭：肾脏病：改善全球预后（KDIGO）争议会议的结论。
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
机构信息
Division of Nephrology, Department of Medicine, Western University and London Health Sciences Centre, London, Ontario, Canada.
Department of Medicine, Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany.
出版信息
Kidney Int. 2019 Jun;95(6):1304-1317. doi: 10.1016/j.kint.2019.02.022. Epub 2019 Apr 30.
The incidence and prevalence of heart failure (HF) and chronic kidney disease (CKD) are increasing, and as such a better understanding of the interface between both conditions is imperative for developing optimal strategies for their detection, prevention, diagnosis, and management. To this end, Kidney Disease: Improving Global Outcomes (KDIGO) convened an international, multidisciplinary Controversies Conference titled Heart Failure in CKD. Breakout group discussions included (i) HF with preserved ejection fraction (HFpEF) and nondialysis CKD, (ii) HF with reduced ejection fraction (HFrEF) and nondialysis CKD, (iii) HFpEF and dialysis-dependent CKD, (iv) HFrEF and dialysis-dependent CKD, and (v) HF in kidney transplant patients. The questions that formed the basis of discussions are available on the KDIGO website http://kdigo.org/conferences/heart-failure-in-ckd/, and the deliberations from the conference are summarized here.
心力衰竭（HF）和慢性肾脏病（CKD）的发病率和患病率正在上升，因此，更好地了解这两种疾病之间的关系对于制定最佳的检测、预防、诊断和管理策略至关重要。为此，肾脏病：改善全球结局（KDIGO）组织了一次题为心力衰竭与慢性肾脏病的国际、多学科争议会议。分组讨论包括：（i）射血分数保留的心力衰竭（HFpEF）和非透析性 CKD；（ii）射血分数降低的心力衰竭（HFrEF）和非透析性 CKD；（iii）HFpEF 和依赖透析的 CKD；（iv）HFrEF 和依赖透析的 CKD；以及（v）肾移植患者中的心力衰竭。会议讨论的基础问题可在 KDIGO 网站上获取，http://kdigo.org/conferences/heart-failure-in-ckd/，会议的审议情况总结如下。
Zotero 插件